PAHO/WHO CC for Epidemiology and Control of Tuberculosis​ 
(ARG-15) 

FACT: Collaborating on the consolidation, analysis and production of tables, figures and graphs related to TB data collected from Member States and in the development of Regional TB Reports 2019 and 2020; also supported the development of TB epidemiological reviews (TB Epi-reviews) in selected countries of the Region, training, and a regional workshop on the Analysis and Use of Tuberculosis Information in the Americas. Activities are targeted at those working on TB and national TB programs.

IMPACT: Better understanding of the epidemiological and programmatic situation of TB in Member States resulting in better monitoring and accountability.

 PAHO/WHO CC for Insecticide Resistance and Insecticide Research on Chagas and Dengue Vectors 
(ARG-29) 

FACT: Participated in the development of the Argentine Network for Insecticide Resistance Monitoring; contributed to the mapping of national and provincial initiatives and the
update of strategies to achieve the elimination of vector transmission of Chagas Disease; and advanced in the installation of a Good Laboratory Practices (GLP) laboratory to 
evaluate insecticide susceptibility in mosquitoes, and produce insecticide
-impregnated papers.  Deliverables targeted at Member States and laboratories working with insecticide resistance surveillance.

IMPACT: Strengthened national insecticide resistance surveillance networks; increased regional capacity for the evaluation of products for vector control based on the use of insecticides; and increased accessibility  of insecticide-impregnated papers. 

PAHO/WHO CC for Training and Research in Urban Zoonoses Control 
(BRA-49) 

FACT: Coordinates the Virtual Network for the Zoonosis Control Centres for the America Region.

IMPACT: Collaboration results in the exchange of experience, good  practices, and technical advice. 

 PAHO/WHO CC in Rabies 
(BRA-75)

FACT: Identified and sequenced the rabies virus from several Member States

IMPACT: Better understanding of the rabies epidemiology.

PAHO/WHO CC for Control and Epidemiology of Rabies in Carnivores 
(CAN-37) 

FACT: Hosted training for national rabies laboratories across the Region.

IMPACT: Building capacity across the Region. 

 PAHO/WHO CC for Research and Training in Parasite Epidemiology and Control 
(CAN-88) 

FACT: Supported the development of a guideline for preventive chemotherapy for Taenia solium
teniasis, disseminated virtually and face-to-face, targeted at neglected infectious diseases control program managers, public health workers, and researchers.

IMPACT: Can be used regionally and globally in Taeniasis endemic regions.

PAHO/WHO CC on
Leishmaniasis Control 
(COL-26) 

FACT: Published “Interactive Atlas of Leishmaniasis in the Americas - Clinical aspects and differential diagnoses,” in Spanish and English, to provide health professionals with the possibility of searching, knowing and interactively analyzing 1,029 photos and illustrations of leishmaniasis and differential diagnosis to support the care of infected patients; hosted a virtual course on NTD-skin - Cutaneous and mucosal Leishmaniasis in the Americas. Deliverables are targeted at health workers, students, researchers, and teachers.

IMPACT: Regional and global impact, since material is accessible to 
any health worker in the Region for
 the diagnosis and care of  leishmaniasis patients.

PAHO/WHO CC for the Study and Control of Dengue 
(CUB-18) 

FACT: Updated clinical management guidelines for arbovirus infections
 for June 2021; developed a dengue course on clinical diagnosis and management (English and Spanish); and a virtual classroom for training of teachers (available on PAHO's Virtual Campus for Public Health). Training is intended for health personnel in charge of the primary care of arboviral diseases.

IMPACT: Since its launch, more than 24,000 health professionals have been trained in 43 countries.  

PAHO/WHO CC for Surveillance of Anti-malarial Drug Resistance 
(FRA-125) 

FACT: Provides services to characterize malaria resistance across countries in the Guiana Shield and Amazonian region, including (1) phenotyping parasites against several antimalarial drugs, (2) genotyping parasites, and (3) genotyping of polymorphic markers;  assists Member States with the molecular analysis as part of Therapeutic Efficacy Study protocols;
 and conducts specific analysis of
 samples from French Guiana, Guyana, and Venezuela, sharing information regarding molecular markers circulating in the Guiana shield area, the absence of drug resistance to artemisinin combination therapies, and information regarding HRP2/HRP3 gene deletion.

IMPACT: Characterization of malaria resistance across countries in the Guiana Shield and Amazonian region thereby providing important information to guide national malaria programs on procurement of Rapid Diagnostic Tests.

PAHO/WHO CC for Training on Malaria Microscopy Diagnosis 
(MEX-29) 

FACT: Offers Malaria Microscopy training to assess the competency for malaria diagnosis; provides PAHO with technical reviews of malaria diagnosis documents and processes in the Region; and collaborated in the technical review of a virtual course on malaria diagnosis. Training is targeted at national reference laboratories of the Region.

IMPACT: Contributes to PAHO’s malaria elimination and global eradication goals to promptly detect, diagnose and treat malaria, and to maintain capacities to prevent reestablishment under quality assurance standards.

PAHO/WHO CC for Reference and Research on Rabies 
(USA-130) 

FACT: Conducted research on rabies control, epidemiology, diagnosis, and training. Deliverables are targeted at zoonosis control centers and national Rabies programs and laboratories from the Region.

IMPACT: Capacity building across the Region.

PAHO/WHO CC on Water and Indoor Air Quality and Food Safety 
(USA-403) 

FACT: Tested the performance of household water treatment (HWT) technologies in removing pathogens from drinking-water; supported the review of the chemical aspects of the Guidelines for Drinking-water Quality (GDWQ), including conducting literature reviews and summarizing risk assessments. Targeted at institutions of health, environment, water and sanitation, as well as academia.

IMPACT: Key for improving the quality of water for the population at risk where the water supply is insecure in our Region and in the which the marginal urban, rural and dispersed rural population is the most affected. Likewise, these technologies are used in emergencies that affect water quality. 

PAHO/WHO CC for Onchocerciasis Diagnostics
(USA-442)  

FACT: Collaborates with Brazil and Venezuela through the onchocerciasis elimination program for the Americas (OEPA) and several countries in Africa on issues related to serological diagnosis and entomological assessments of the impact of Mass Drug Administration (MDA) elimination programs.  

IMPACT: Entomological and serological assessments are crucial for towards  the elimination of onchocerciasis transmission. These assessments are used to make decisions regarding the Mass Drug Administration strategy such as stopping treatment and verifying the elimination of transmission. 

PAHO/WHO CC for Trachoma 
(USA-443) 

FACT:  Conducted consultations to identify operational research gaps in the use of serology as a tool to strengthen surveillance of trachoma, resulting in a manuscript on the current status and priorities for future investigation; provided technical assistance, training, reagents, materials, and supplies to public health laboratories in Mexico and Paraguay on the use of Multiplex Bead Assay (MBA) in the Multiplex Initiative; provides technical support on population-based integrated serosurveillance survey protocols, training and supplies for implementation of the surveys, and support for analysis and interpretation of data produced in Brazil, Mexico, and Paraguay; also provided technical assistance to Guatemala and Guyana for the inclusion of serology for multiple diseases within surveys for neglected infectious diseases and is analyzing samples for results in 2021. Targeted mainly at Ministries of Health and national public health labs, where trachoma is a public health problem.

IMPACT: Improved trachoma surveillance at the regional and global level through the development of innovative surveillance tools which promote integrated and inter programmatic work.